Innovation and the Limitation of Problem-Solving.
a blog post by Managing Partner, Aidan Petrie
In the years that I have taught innovation and worked with many hundreds of companies, big and small, we hear over and over again that we have to go in search of problems to solve as a route to innovation.
Curveball Pitch Night
On May 28th, 2020, NEMIC held its first Curveball Pitch Night and first virtual pitch event with 3 startups pitching and 12 investors in attendance. Curveball at NEMIC is a play on and similar to their Softball Pitch Events.
Emergency Use Authorization. What it is and what it is NOT. Blog post by Managing Partner, Aidan Petrie
There is some confusion over the EUA guidelines, what they mean for innovators in the MedTech field, how to use them well and what to watch out for. Read the blog for clarity on EUA submissions.
Med Tech as an Investment. Blog post by Managing Partner, Aidan Petrie
We believe that Med Tech offers a very interesting investment opportunity and methodology. Strangely, the FDA's development process configures that methodology. How so..?
Call for RI Med Tech Companies to Showcase at Access RI Med Tech
Are you a part of Rhode Island's Med Tech Ecosystem? Are you part of an institution, non-profit, startup, design firm, research group, service provider, or just a general Med Tech enthusiast?
Register to showcase your work, products, research, or services, at the Med Tech "Science Fair", part of Access RI Med Tech, a showcase of Rhode Island's Med Tech ecosystem on May 7th, 2020.
Softball at NEMIC
Five NEMIC member startups, seven venture capitalists, and one in-valuable evening. Softball at NEMIC.
Learn what it’s all about and how you can participate in this pitch event.
Calling All Startups! Business Plan & Pitch Deck Immersion Program
Do you have a biomedical technology or medical innovation you want to take to market?
Learn how to wow investors and secure funding to launch your business through this 10-week Immersion Program from the New England Medical Innovation Center (NEMIC) and Advance-CTR.